Paul Little | CFO |
David-Alexandre Gros | CEO |
Steve Perrin | President and Chief Scientific Officer |
Jeff Bornstein | Chief Medical Officer |
Thomas Smith | SVB Securities |
Rami Katkhuda | LifeSci Capital |
Greetings, and welcome to Eledon Pharmaceuticals Second Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded today, August 11, 2022. I would now like to turn the conference call over to Paul Little, Chief Financial Officer of Eledon.